ELECSYS BRAHMS PCT 05056888003

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-01-26 for ELECSYS BRAHMS PCT 05056888003 manufactured by Roche Diagnostics.

Event Text Entries

[98588072] (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[98588073] The customer complained of high results for 1 patient tested for elecsys brahms pct (pct) that did not correspond to the patient? S clinical picture. The patient? S pct results have been consistently over 100 ng/ml. The results have been reported outside of the laboratory where the high results were questioned by the medical doctor. The high results were questioned as the patient does not have sepsis and the patient? S crp results were low. A high pct result can also be caused by medullary thyroid carcinoma (mtc). This disease has been ruled out for the patient by measuring calcitonin results which were low. There was no allegation that an adverse event occurred. The instrument type and serial number were not provided.
Patient Sequence No: 1, Text Type: D, B5


[132930832] Lot number and expiration date were updated. The instrument was a cobas e 411 immunoassay analyzer with a serial number of (b)(4). A new sample was obtained on (b)(6) 2018 and the pct result was 91. 1 ng/ml at the customer site. It was clarified that when attempts were made to test this patient prior to the result on (b)(6) 2018, the result on (b)(6) 2018 was >100 ng/ml with a data flag. The patient has been in the hospital since (b)(6) 2017 due to severe pancreatitis including septic shock as well as organ failure. Pct was high from the beginning with elecsys pct values always >100 ng/ml with a data flag. Crp was also high, but since the last week in (b)(6) 2018, it has decreased to 30 mg/l. Since the last week in (b)(6) 2018, the patient is awake and mobile, but is still hospitalized; the patient is not receiving catecholamines any longer. The patient has deliric syndrome ("delirantes syndrome") including positive blood cultures which do not correlate with the clinical picture since the patient shows no fever. The patient does suffer from ongoing intestinal fistulas. The high pct values triggered a change in treatment during the time the patient was suffering from clinical septic shock. The pancreatitis was treated conservatively for awhile and the first operations started at the end of (b)(6) 2017. These operations led to the intestinal fistulas.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2018-00250
MDR Report Key7221964
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-01-26
Date of Report2018-07-24
Date of Event2018-01-07
Date Mfgr Received2018-01-09
Date Added to Maude2018-01-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameELECSYS BRAHMS PCT
Generic NameDEVICE TO DETECT AND MEASURE PROCALCITONIN (PCT) IN HUMAN CLINICAL SPECIMENS
Product CodePMT
Date Received2018-01-26
Model NumberNA
Catalog Number05056888003
Lot Number273163
ID NumberNA
Device Expiration Date2018-10-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-01-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.